Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PI(3,4,5)P(3) produced by the activated PI3-kinase is a key lipid second messenger in cell signaling downstream of insulin.
Skeletal muscle and kidney-enriched inositol phosphatase
(
SKIP
) identified as a 5'-inositol phosphatase that hydrolyzes PI(3,4,5) P(3) to PI(3,4)P(2), negatively regulates the insulin-induced glycogen synthesis in skeletal muscle. However the mechanism by which this occurs remains unclear. To elucidate the function of
SKIP
in glycogen synthesis, we employed RNAi techniques to knockdown the
SKIP
gene in differentiating C2C12 myoblasts. Insulin-induced phosphorylation of Akt (protein kinase B) and
GSK
-3beta (Glycogen synthase kinase), subsequent dephosphorylation of glycogen synthase and glycogen synthesis were increased by inhibiting the expression of
SKIP
, whereas the insulin-induced glycogen synthesis was decreased by overexpression of WT-
SKIP
. Our results suggest that
SKIP
plays a negative regulatory role in Akt/
GSK
-3beta/GS (glycogen synthase) pathway leading to glycogen synthesis in myocytes.
...
PMID:Knockdown of endogenous SKIP gene enhanced insulin-induced glycogen synthesis signaling in differentiating C2C12 myoblasts. 1925 Jun 14